泰达生物(08189)澄清:向一名员工授出400万股奖励股份 占已发行H股0.278%

公告速递
Oct 26

天津泰达生物医学工程股份有限公司(08189,以下简称“泰达生物”)10月26日发布澄清公告,就10月21日公布的股份奖励计划授出事项作出补充说明。

公告显示,公司已向一名承授人授出4,000,000股奖励股份。该批股份相当于授出日期起十二个月内将发行及已发行股份中:

1. 约占已发行H股总数的0.278%; 2. 约占已发行股份总数(不包括库存股份)的0.187%。

泰达生物指出,鉴于该承授人为集团员工且同时担任公司一家附属公司股东及董事,本次授出并未导致其在过去十二个月内因任何股份激励计划获得的股份发行总额超过已发行H股或已发行股份(不包括库存股份)1%的上限,因而无需根据香港联交所GEM《上市规则》第23.04(4)条取得股东批准。

公司强调,除上述澄清及补充外,10月21日公告的其他内容保持不变。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10